Tokyo, Dec. 9 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060004) titled 'Evaluation of Drainage Methods After Endoscopic Submucosal Dissection Including the Papilla (ESDIP) for Papillary-Involving Duodenal Tumors' on Dec. 9.
Study Type:
Observational
Primary Sponsor:
Institute - Keio University School of Medicine
Condition:
Condition - deuodenal tumor
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the usefulness of gel-assisted drainage during cannulation after endoscopic submucosal dissection (ESD) for duodenal tumors.
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - 20
years-old
Gender - Male and Female
Key inclusion criteria - 1.Patients undergoing biliary and pancreatic duct cannulation for drainage after ESDIP for duodenal adenoma
2.Patients aged >19 and <100 years at the time of consent
3.Patients who provide written informed consent to participate in this study
Key exclusion criteria - 1.Patients with invasive cancer who are eligible for surgical treatment
2.Cases in which the attending physician judges participation in this study to be inappropriate
3.Patients who withdraw their consent and refuse participation after enrollment
Target Size - 20
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 12 Month 07 Day
Date of IRB - 2018 Year 12 Month 12 Day
Anticipated trial start date - 2025 Year 12 Month 09 Day
Last follow-up date - 2030 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068628
Disclaimer: Curated by HT Syndication.
